Vishal Dhikale, Associate Vice President at Avalon Consulting, unpacks the implications of impending US reciprocal tariffs on India’s export-driven bioscience sector. In BioVoice News, he highlights how rising input costs, disrupted supply chains, and regulatory uncertainty threaten India’s global competitiveness. However, he also outlines strategic responses diversifying sourcing, embracing AI, and strengthening domestic capabilities that can turn this challenge into an opportunity for long-term sectoral resilience.
Loading...
Reload document
Open in new tab 